Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.

Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, van Vollenhoven RF, de Wit M, Aletaha D, Aringer M, Askling J, Balsa A, Boers M, den Broeder AA, Buch MH, Buttgereit F, Caporali R, Cardiel MH, De Cock D, Codreanu C, Cutolo M, Edwards CJ, van Eijk-Hustings Y, Emery P, Finckh A, Gossec L, Gottenberg JE, Hetland ML, Huizinga TWJ, Koloumas M, Li Z, Mariette X, Müller-Ladner U, Mysler EF, da Silva JAP, Poór G, Pope JE, Rubbert-Roth A, Ruyssen-Witrand A, Saag KG, Strangfeld A, Takeuchi T, Voshaar M, Westhovens R, van der Heijde D.

Ann Rheum Dis. 2020 Jan 22. pii: annrheumdis-2019-216655. doi: 10.1136/annrheumdis-2019-216655. [Epub ahead of print]

PMID:
31969328
2.

Glucocorticoid receptor polymorphisms in rheumatoid arthritis: results from a single centre.

Bazsó A, Kövesdi A, Rásonyi R, Nagy E, Poór G, Patócs A, Kiss E.

Clin Exp Rheumatol. 2019 Nov 20. [Epub ahead of print]

PMID:
31820730
3.

Comorbidity clusters in generalized osteoarthritis among female patients: A cross-sectional study.

Kovari E, Kaposi A, Bekes G, Kiss Z, Kurucz R, Mandl P, Balint GP, Poor G, Szendroi M, Balint PV.

Semin Arthritis Rheum. 2019 Sep 9. pii: S0049-0172(19)30233-1. doi: 10.1016/j.semarthrit.2019.09.001. [Epub ahead of print]

PMID:
31522761
4.

The potential pathogenic role of glucocorticoid receptor polymorphisms in systemic lupus erythematosus and rheumatoid arthritis.

Bazsó A, Szappanos Á, Kövesdi A, Rásonyi R, Nagy E, Patócs A, Poór G, Kiss E.

Autoimmun Rev. 2019 Oct;18(10):102362. doi: 10.1016/j.autrev.2019.102362. Epub 2019 Aug 8. No abstract available.

PMID:
31401344
5.

Polymorphisms of human glucocorticoid receptor gene in systemic lupus erythematosus: a single-centre result.

Bazsó A, Szappanos Á, Rásonyi R, Nagy E, Farkas A, Várnai B, Patócs A, Kiss E, Poór G.

Clin Rheumatol. 2019 Jul;38(7):1979-1984. doi: 10.1007/s10067-019-04478-5. Epub 2019 Mar 9.

PMID:
30850964
6.

Effect of a balance-training programme on postural balance, aerobic capacity and frequency of falls in women with osteoporosis: A randomized controlled trial.

Miko I, Szerb I, Szerb A, Bender T, Poor G.

J Rehabil Med. 2018 Jun 15;50(6):542-547. doi: 10.2340/16501977-2349.

7.

Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression.

Zámbó B, Bartos Z, Mózner O, Szabó E, Várady G, Poór G, Pálinkás M, Andrikovics H, Hegedűs T, Homolya L, Sarkadi B.

Sci Rep. 2018 May 10;8(1):7487. doi: 10.1038/s41598-018-25695-z.

8.

The Hungarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Orbán I, Constantin T, Dérfalvi B, Sevcic K, Garan D, Káposzta R, Poór G, Kiss E, Ponyi A, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):243-250. doi: 10.1007/s00296-018-3955-y. Epub 2018 Apr 7.

9.

[Helping reintegration of patients suffering from chronic musculoskeletal diseases with decreased working ability in the National Institute of Rheumatology and Physiotherapy, Budapest, Hungary].

Sallai JR, Hunka A, Héjj G, Bálint G, Poór G.

Orv Hetil. 2017 Apr;158(17):662-667. doi: 10.1556/650.2017.30526. Hungarian.

PMID:
28434244
10.

Degenerative inter-vertebral disc disease osteochondrosis intervertebralis in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over.

Armbrecht G, Felsenberg D, Ganswindt M, Lunt M, Kaptoge SK, Abendroth K, Aroso Dias A, Bhalla AK, Cannata Andia J, Dequeker J, Eastell R, Hoszowski K, Lyritis G, Masaryk P, van Meurs J, Miazgowski T, Nuti R, Poór G, Redlund-Johnell I, Reid DM, Schatz H, Todd CJ, Woolf AD, Rivadeneira F, Javaid MK, Cooper C, Silman AJ, O'Neill TW, Reeve J; European Vertebral Osteoporosis Study and European Prospective Osteoporosis Study Groups.

Rheumatology (Oxford). 2017 Jul 1;56(7):1189-1199. doi: 10.1093/rheumatology/kex040.

11.

Reduced volumes of the CA1 and CA4-dentate gyrus hippocampal subfields in systemic lupus erythematosus.

Bódi N, Polgár A, Kiss E, Mester Á, Poór G, Kéri S.

Lupus. 2017 Nov;26(13):1378-1382. doi: 10.1177/0961203317701845. Epub 2017 Mar 29.

PMID:
28355989
12.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D.

Ann Rheum Dis. 2017 Jun;76(6):960-977. doi: 10.1136/annrheumdis-2016-210715. Epub 2017 Mar 6. Review.

13.

EULAR/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures.

Lems WF, Dreinhöfer KE, Bischoff-Ferrari H, Blauth M, Czerwinski E, da Silva J, Herrera A, Hoffmeyer P, Kvien T, Maalouf G, Marsh D, Puget J, Puhl W, Poor G, Rasch L, Roux C, Schüler S, Seriolo B, Tarantino U, van Geel T, Woolf A, Wyers C, Geusens P.

Ann Rheum Dis. 2017 May;76(5):802-810. doi: 10.1136/annrheumdis-2016-210289. Epub 2016 Dec 22. Review.

14.

Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE Patients.

Kremlitzka M, Mácsik-Valent B, Polgár A, Kiss E, Poór G, Erdei A.

J Immunol Res. 2016;2016:5758192. Epub 2016 Nov 17.

15.

Improved clinical, functional and work outcomes in spondyloarthritides during real-life adalimumab treatment in central-eastern Europe.

Szántó S, Poór G, Opris D, Iaremenko O, Procházková L, Kuuse R, Nagy O, Chernyshov V, Géher P.

J Comp Eff Res. 2016 Aug;5(5):475-85. doi: 10.2217/cer-2016-0020. Epub 2016 Jul 15.

PMID:
27417564
16.

Patients' access to biological therapy in chronic inflammatory conditions; per capita GDP does not explain the intercountry differences.

Gulácsi L, Rencz F, Poór G, Szekanecz Z, Brodszky V, Baji P, Péntek M.

Ann Rheum Dis. 2016 May;75(5):942-3. doi: 10.1136/annrheumdis-2015-208741. Epub 2016 Feb 17. No abstract available.

PMID:
26888946
17.

Effectiveness of balance training programme in reducing the frequency of falling in established osteoporotic women: a randomized controlled trial.

Mikó I, Szerb I, Szerb A, Poor G.

Clin Rehabil. 2017 Feb;31(2):217-224. doi: 10.1177/0269215516628616. Epub 2016 Jul 10.

PMID:
26825109
18.

[Polymyalgia rheumatica update, 2015].

Schmidt Z, Poór G.

Orv Hetil. 2016 Jan 3;157(1):2-12. doi: 10.1556/650.2016.30314. Review. Hungarian.

PMID:
26708681
19.

[Recent advances in the treatment of antineutrophil cytoplasm antibody associated vasculitides].

Szabó MZ, Pálfi P, Bazsó A, Poór G, Kiss E.

Orv Hetil. 2015 Oct 11;156(41):1653-60. doi: 10.1556/650.2015.30273. Review. Hungarian.

PMID:
26551168
20.

Systemic Autoimmune, Rheumatic Diseases and Coinciding Psoriasis: Data from a Large Single-Centre Registry and Review of the Literature.

Bazsó A, Szodoray P, Szappanos Á, Korda J, Pálfi P, Kiss E, Poór G.

Mediators Inflamm. 2015;2015:657907. doi: 10.1155/2015/657907. Epub 2015 Aug 3. Review.

21.

Vertebral Scheuermann's disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over.

Armbrecht G, Felsenberg D, Ganswindt M, Lunt M, Kaptoge SK, Abendroth K, Aroso A, Banzer D, Bhalla AK, Dequeker J, Eastell R, Hoszowski K, Lyritis G, Delmas PD, Masaryk P, Miazgowski T, Cannata J, Nuti R, Oei L, Poor G, Redlund-Johnell I, Reid DM, Reisinger W, Schatz H, Todd CJ, Woolf AD, Javaid K, Rivadeneira F, Silman AJ, Cooper C, O'Neill TW, Reeve J; European Vertebral Osteoporosis Study and European Prospective Osteoporosis Study Groups.

Osteoporos Int. 2015 Oct;26(10):2509-19. doi: 10.1007/s00198-015-3170-6. Epub 2015 May 29.

PMID:
26021761
22.

Polymorphisms of CSF1 and TM7SF4 genes in a case of mild juvenile Paget's disease found using next-generation sequencing.

Donáth J, Speer G, Kósa JP, Árvai K, Balla B, Juhász P, Lakatos P, Poór G.

Croat Med J. 2015 Apr;56(2):145-51.

23.

Nicotinic acetylcholine receptors modulate osteoclastogenesis.

Mandl P, Hayer S, Karonitsch T, Scholze P, Győri D, Sykoutri D, Blüml S, Mócsai A, Poór G, Huck S, Smolen JS, Redlich K.

Arthritis Res Ther. 2016 Mar 12;18:63. doi: 10.1186/s13075-016-0961-x.

24.

The importance of glucocorticoid receptors in systemic lupus erythaematosus. A systematic review.

Bazsó A, Szappanos Á, Patócs A, Poór G, Shoenfeld Y, Kiss E.

Autoimmun Rev. 2015 Apr;14(4):349-51. doi: 10.1016/j.autrev.2014.12.007. Epub 2014 Dec 16. Review.

PMID:
25526806
25.

Tissue-Specific Glucocorticoid Signaling May Determine The Resistance Against Glucocorticoids In Autoimmune Diseases.

Szappanos A, Nagy Z, Kovács B, Poór G, Tóth M, Rácz K, Kiss E, Patócs A.

Curr Med Chem. 2014 Dec 16. [Epub ahead of print]

PMID:
25511778
26.

Importance of intestinal microenvironment in development of arthritis. A systematic review.

Bazsó A, Szodoray P, Sütő G, Shoenfeld Y, Poór G, Kiss E.

Immunol Res. 2015 Feb;61(1-2):172-6. doi: 10.1007/s12026-014-8593-1. Review.

PMID:
25407648
27.

Clinical and radiological dissociation of anti-TNF plus methotrexate treatment in early rheumatoid arthritis in routine care: results from the ABRAB study.

Juhász P, Mester A, Biró AJ, Héjj G, Poór G.

BMC Musculoskelet Disord. 2014 Jul 24;15:251. doi: 10.1186/1471-2474-15-251.

28.

Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries.

Péntek M, Poór G, Wiland P, Olejárová M, Brzosko M, Codreanu C, Brodszky N, Gulácsi L.

Eur J Health Econ. 2014 May;15 Suppl 1:S35-43. doi: 10.1007/s10198-014-0592-6. Epub 2014 May 16. Review.

PMID:
24832834
29.

Comparative statistical analysis of osteoporosis treatment based on Hungarian claims data and interpretation of the results in respect to cost-effectiveness.

Lakatos P, Tóth E, Szekeres L, Poór G, Héjj G, Marton I, Takács I.

Osteoporos Int. 2014 Aug;25(8):2077-87. doi: 10.1007/s00198-014-2733-2. Epub 2014 May 13.

PMID:
24819455
30.

[The stiff-person syndrome: a brief review and report of two cases].

Kemény Z, Pálfi P, Demeter J, Poór G, Kiss E, Bálint P.

Orv Hetil. 2013 Dec 1;154(50):1984-90. doi: 10.1556/OH.2013.29773. Review. Hungarian.

PMID:
24317357
31.

Aseptic necrosis at multiple localisations in a lupus patient with lymphoma.

Bazso A, Bazso T, Szodoray P, Poor G, Kiss E.

Osteoporos Int. 2014 Apr;25(4):1415-7. doi: 10.1007/s00198-013-2589-x. Epub 2013 Dec 3.

32.

Recognition of new citrulline-containing peptide epitopes by autoantibodies produced in vivo and in vitro by B cells of rheumatoid arthritis patients.

Szarka E, Babos F, Magyar A, Huber K, Szittner Z, Papp K, Prechl J, Pozsgay J, Neer Z, Ádori M, Nagy G, Rojkovich B, Gáti T, Kelemen J, Baka Z, Brózik M, Pazár B, Poór G, Hudecz F, Sármay G.

Immunology. 2014 Feb;141(2):181-91. doi: 10.1111/imm.12175.

33.

[Behcet's disease: a rarely recognized orphan disorder].

Kiss E, Dohán J, Németh J, Poór G.

Orv Hetil. 2013 Jan 20;154(3):93-101. doi: 10.1556/OH.2013.29528. Review. Hungarian.

PMID:
23315224
34.

Marked diversity of IL23R gene haplotype variants in rheumatoid arthritis comparing with Crohn's disease and ankylosing spondylitis.

Szabo M, Safrany E, Pazar B, Melegh BI, Kisfali P, Poor G, Figler M, Szekanecz Z, Czirjak L, Melegh B.

Mol Biol Rep. 2013 Jan;40(1):359-63. doi: 10.1007/s11033-012-2068-z. Epub 2012 Oct 10.

PMID:
23054009
35.

Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients.

Kremlitzka M, Polgár A, Fülöp L, Kiss E, Poór G, Erdei A.

Int Immunol. 2013 Jan;25(1):25-33. doi: 10.1093/intimm/dxs090. Epub 2012 Sep 7.

PMID:
22962438
36.

[Report from the 2011 scientific meeting of the Környey Society. Part 1].

Pálffy G, Poór G, Környey E, Illés Z, Kopa J, Kovács N, Barzo P, Bereczki D, Bodosi M, Csiba L, Dóczi T, Fekete S, Gallyas F, Hegedűs K, Komoly S, Szirmai I, Vécsei L.

Ideggyogy Sz. 2011 Nov 30;64(11-12):418-26. Hungarian. No abstract available.

PMID:
22611621
37.

Psychosocial, educational, and somatic factors in chronic nonspecific low back pain.

Vereckei E, Susanszky E, Kopp M, Ratko I, Czimbalmos A, Nagy Z, Palkonyai E, Hodinka L, Temesvari PI, Kiss E, Töro K, Poor G.

Rheumatol Int. 2013 Mar;33(3):587-92. doi: 10.1007/s00296-012-2398-0. Epub 2012 Apr 3. Erratum in: Rheumatol Int. 2013 Aug;33(8):2187. multiple author names corrected.

PMID:
22476243
38.

Patient-reported outcomes in polymyalgia rheumatica.

Matteson EL, Maradit-Kremers H, Cimmino MA, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Slott Jensen H, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Cantini F, Nannini C, Macchioni P, Pipitone N, Del Amo M, Espígol-Frigolé G, Cid MC, Martínez-Taboada VM, Nordborg E, Direskeneli H, Aydin SZ, Ahmed K, Hazelman B, Pease C, Wakefield RJ, Luqmani R, Abril A, Marcus R, Gonter NJ, Maz M, Crowson CS, Dasgupta B.

J Rheumatol. 2012 Apr;39(4):795-803. doi: 10.3899/jrheum.110977. Epub 2012 Mar 15.

39.

2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Dasgupta B, Cimmino MA, Kremers HM, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Jensen HS, Duhaut P, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Nannini C, Cantini F, Macchioni P, Pipitone N, Del Amo M, Espígol-Frigolé G, Cid MC, Martínez-Taboada VM, Nordborg E, Direskeneli H, Aydin SZ, Ahmed K, Hazleman B, Silverman B, Pease C, Wakefield RJ, Luqmani R, Abril A, Michet CJ, Marcus R, Gonter NJ, Maz M, Carter RE, Crowson CS, Matteson EL.

Arthritis Rheum. 2012 Apr;64(4):943-54. doi: 10.1002/art.34356.

40.

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Jensen HS, Duhaut P, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Nannini C, Cantini F, Macchioni P, Pipitone N, Amo MD, Espígol-Frigolé G, Cid MC, Martínez-Taboada VM, Nordborg E, Direskeneli H, Aydin SZ, Ahmed K, Hazleman B, Silverman B, Pease C, Wakefield RJ, Luqmani R, Abril A, Michet CJ, Marcus R, Gonter NJ, Maz M, Carter RE, Crowson CS, Matteson EL.

Ann Rheum Dis. 2012 Apr;71(4):484-92. doi: 10.1136/annrheumdis-2011-200329.

41.

[Systemic autoimmune disorders and pregnancy].

Kiss E, Kiss CG, Poór G.

Orv Hetil. 2011 Oct 23;152(43):1715-23. doi: 10.1556/OH.2011.29216. Review. Hungarian.

PMID:
21983397
42.

[Paget's disease: clinical update].

Donáth J, Poór G.

Orv Hetil. 2011 Aug 14;152(33):1337-46. doi: 10.1556/OH.2011.29174. Review. Hungarian.

PMID:
21824861
43.

Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire.

Haraoui B, Smolen JS, Aletaha D, Breedveld FC, Burmester G, Codreanu C, Da Silva JP, de Wit M, Dougados M, Durez P, Emery P, Fonseca JE, Gibofsky A, Gomez-Reino J, Graninger W, Hamuryudan V, Jannaut Peña MJ, Kalden J, Kvien TK, Laurindo I, Martin-Mola E, Montecucco C, Santos Moreno P, Pavelka K, Poor G, Cardiel MH, Stanislawska-Biernat E, Takeuchi T, van der Heijde D; Treat to Target Taskforce.

Ann Rheum Dis. 2011 Nov;70(11):1999-2002. doi: 10.1136/ard.2011.154179. Epub 2011 Jul 29.

44.

[Diabetes and bone metabolism].

Ruzicska E, Poór G.

Orv Hetil. 2011 Jul 17;152(29):1156-60. doi: 10.1556/OH.2011.29147. Review. Hungarian.

PMID:
21712180
45.

Experiences with tumour necrosis factor-{alpha} inhibitors in patients with juvenile idiopathic arthritis: Hungarian data from the National Institute of Rheumatology and Physiotherapy Registry.

Sevcic K, Orban I, Brodszky V, Bazso A, Balogh Z, Poor G, Kiss E.

Rheumatology (Oxford). 2011 Jul;50(7):1337-40. doi: 10.1093/rheumatology/ker103. Epub 2011 Mar 3.

PMID:
21372001
46.

Genetic and immunological processes in the pathomechanism of gluten-sensitive enteropathy and associated metabolic bone disorders.

Vereckei E, Szodoray P, Poor G, Kiss E.

Autoimmun Rev. 2011 Apr;10(6):336-40. doi: 10.1016/j.autrev.2010.12.001. Epub 2010 Dec 21. Review.

PMID:
21172460
47.

[Biotechnological advances in monoclonal antibody therapy: the RANK ligand inhibitor antibody].

Kiss E, Kuluncsics Z, Kiss Z, Poór G.

Orv Hetil. 2010 Dec 26;151(52):2137-44. doi: 10.1556/OH.2010.29010. Review. Hungarian.

PMID:
21147699
48.

The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary.

Szodoray P, Tarr T, Bazso A, Poor G, Szegedi G, Kiss E.

Scand J Rheumatol. 2011 Mar;40(2):122-6. doi: 10.3109/03009742.2010.507220. Epub 2010 Oct 26.

PMID:
20977384
49.

Devic's syndrome and SLE: challenges in diagnosis and therapeutic possibilities based on two overlapping cases.

Polgár A, Rózsa C, Müller V, Matolcsi J, Poór G, Kiss EV.

Autoimmun Rev. 2011 Jan;10(3):171-4. doi: 10.1016/j.autrev.2010.09.021. Epub 2010 Oct 12.

PMID:
20920613
50.

Overlapping juvenile idiopathic arthritis and systemic lupus erythematosus: a case report.

Bazsó A, Sevcic K, Orbán I, Poór G, Balogh Z, Kiss E.

Rheumatol Int. 2011 May;31(5):695-8. doi: 10.1007/s00296-010-1594-z. Epub 2010 Jul 30.

PMID:
20676642

Supplemental Content

Support Center